中成药治疗COVID-19的潜在作用机制综述
本文综述了SARS-CoV-2的潜在靶点及国家与地方推荐用于COVID-19的22种中成药的理论依据与临床疗效,并分析其药物组成、潜在活性成分、靶点、信号通路及抗炎免疫调节、抗病毒、改善肺损伤、解热和器官保护等可能机制,为临床应用中成药提供信息。
要点
- 中成药在COVID-19医学观察期及轻、中、重、危重症和恢复期治疗中均有应用并取得疗效。
- 综述汇总了国家卫健委、中医药管理局及地方省市推荐的22种中成药。
- 中成药可能通过抗炎免疫调节、抗病毒、改善肺损伤、解热和器官保护等机制发挥作用。
核心结论
- 中成药作为中医药不可或缺的部分,在COVID-19防治中发挥不可替代的作用,并在不同临床分期取得显著疗效。
研究设计与样本
- 综述汇总了国家卫健委、中医药管理局及地方省市推荐的22种中成药,并分析其药物组成、潜在活性成分、靶点、信号通路及可能机制。
主要发现
- 中成药在医学观察期及轻、中、重、危重症和恢复期治疗中均有应用并取得疗效。
- 中成药可能通过抗炎与免疫调节、抗病毒、改善肺损伤、解热和器官保护等机制发挥作用。
临床怎么用
- 可参考本综述汇总的22种推荐中成药及其潜在机制,在COVID-19不同临床分期中合理选用中成药。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Coronavirus disease 2019 (COVID-19) is an emergent infectious pneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is highly contagious and pathogenic. COVID-19 has rapidly swept across the world since it was first discovered in December 2019 and has drawn significant attention worldwide. During the early stages of the outbreak in China, traditional Chinese medicines (TCMs) were involved in the whole treatment process. As an indispensable part of TCM, Chinese patent medicines (CPMs) played an irreplaceable role in the prevention and treatment of this epidemic. Their use has achieved remarkable therapeutic efficacy during the period of medical observation and clinical treatment of mild, moderate, severe, and critical cases and during convalescence. In order to better propagate and make full use of the benefits of TCM in the treatment of COVID-19, this review will summarize the potential target of SARS-CoV-2 as well as the theoretical basis and clinical efficacy of recommended 22 CPMs by the National Health Commission and the Administration of TCM and local provinces or cities in the treatment of COVID-19. Additionally, the study will further analyze the drug composition, potential active ingredients, potential targets, regulated signaling pathways, and possible mechanisms for COVID-19 through anti-inflammatory and immunoregulation, antiviral, improve lung injury, antipyretic and organ protection to provide meaningful information about the clinical application of CPMs.
引用
- Yang ZH, Wang B, Ma Q, et al. Potential Mechanisms of Action of Chinese Patent Medicines for COVID-19: A Review. Front Pharmacol. 2021. PMID: 34335247. doi:10.3389/fphar.2021.668407
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。